SPONSOR
Groupe Oncologie Radiotherapie Tete et Cou
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)Locally Advanced Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Groupe Oncologie Radiotherapie Tete et Cou
How many clinical trials has Groupe Oncologie Radiotherapie Tete et Cou sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Groupe Oncologie Radiotherapie Tete et Cou, of which 2 are actively recruiting participants. These trials cover conditions including Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Groupe Oncologie Radiotherapie Tete et Cou research focus on?
Groupe Oncologie Radiotherapie Tete et Cou clinical trials span Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Groupe Oncologie Radiotherapie Tete et Cou clinical trial?
To participate in a Groupe Oncologie Radiotherapie Tete et Cou trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Groupe Oncologie Radiotherapie Tete et Cou trials with current recruitment status updated daily.
Clinical Trials by Groupe Oncologie Radiotherapie Tete et Cou
NCT07264075 Phase 3
Recruiting
Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
NCT06959108 Phase 2
Recruiting
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck
Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology